quantisnow
FeedTopReportsPricing
⌘K
Live feed
00:15:04·50d
SECFiling
RAPT Therapeutics Inc. logo

SEC Form EFFECT filed by RAPT Therapeutics Inc.

RAPT· RAPT Therapeutics Inc.
Health Care
Original source

Companies

  • RAPT
    RAPT Therapeutics Inc.
    Health Care

Recent analyst ratings

  • Jan 9UpdatePiper Sandler$95.00
  • Oct 27UpdateGuggenheim$70.00
  • Oct 20UpdateAnalyst$55.00
  • Oct 13UpdateBarclays$35.00
  • Sep 26UpdateLeerink Partners$37.00
  • Jul 30UpdateAnalyst$14.00

Related

  • SEC37d
    SEC Form 15-12G filed by RAPT Therapeutics Inc.
  • INSIDER50d
    Director Lyons-Williams Lori closing all direct ownership in the company (SEC Form 4)
  • INSIDER50d
    Director Gray Mary Ann closing all direct ownership in the company (SEC Form 4)
  • INSIDER50d
    Director Giordano Michael F closing all direct ownership in the company (SEC Form 4)
  • INSIDER50d
    Director Dombkowski Ashley L. closing all direct ownership in the company (SEC Form 4)
  • INSIDER50d
    CHIEF FINANCIAL OFFICER Young Rodney Kb closing all direct ownership in the company (SEC Form 4)
  • INSIDER50d
    CHIEF SCIENTIFIC OFFICER Brockstedt Dirk G. closing all direct ownership in the company (SEC Form 4)
  • INSIDER50d
    PRESIDENT AND CEO Wong Brian Russell closing all direct ownership in the company (SEC Form 4)
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022